Global Cord Blood Co. (NYSE:CO – Get Free Report) rose 0.3% during trading on Friday . The stock traded as high as $0.9535 and last traded at $0.9535. 335 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 216,519 shares. The stock had previously closed at $0.9510.
Global Cord Blood Stock Performance
The stock has a 50 day moving average of $0.95 and a 200 day moving average of $0.97. The stock has a market capitalization of $115.60 million, a P/E ratio of 1.49 and a beta of 0.16.
Global Cord Blood Company Profile
Global Cord Blood Corporation (NYSE: CO) is a leading operator of umbilical cord blood banking services in the People’s Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.
In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.
Featured Articles
- Five stocks we like better than Global Cord Blood
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.
